(Me<sub>3</sub>Si)<sub>3</sub>SiH-Mediated Intermolecular Radical Perfluoroalkylation Reactions of Olefins in Water
作者:Sebastián Barata-Vallejo、Al Postigo
DOI:10.1021/jo100901z
日期:2010.9.17
the best radical initiator. We also found that water exerts a relevant solvent effect on the rates of perfluoroalkyl radical additions onto double bonds and the H atom abstraction from the silane. Our account provides a versatile and convenient method to achieve perfluoroalkylation reactions of alkenes in water to render perfluoroalkylated alkanes as key intermediates in the synthesis of fluorophors and
[EN] FLUOROUS METAL CHELATES COMPOSITIONS<br/>[FR] COMPOSITIONS DE CHÉLATES MÉTALLIQUES FLUORITIQUES
申请人:THE REGENTS OF THE UNIVEFISITY OF CALIFORNIA
公开号:WO2020118307A1
公开(公告)日:2020-06-11
This disclosure provides compositions of SALTAME core containing compounds and associated methods for use in tracking cells by magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and related methods.
Liquid pharmaceutical composition for the delivery of active ingredients
申请人:Theisinger Bastian
公开号:US11160865B2
公开(公告)日:2021-11-02
The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble and/or hydrolytically sensitive drug substances. The compositions are designed as suspensions and have superior physical properties which make them highly useful as pharmaceutical delivery systems. The compositions may be administered topically into the eye, or injected via the subcutaneous or intramuscular route. The invention further provides kits comprising such compositions.
Topical ophthalmological atropine free base compositions
申请人:ADS THERAPEUTICS LLC
公开号:US11191751B1
公开(公告)日:2021-12-07
A topical ophthalmological composition includes a muscarinic receptor antagonist as an active pharmaceutical ingredient; and a semifluorinated alkane, as a liquid vehicle. The topical ophthalmological composition treats an ocular disease.